Common drugs for type 2 diabetes and obesity do not increase breast cancer risk
By habiba
Commonly used medications for type 2 diabetes and obesity called glucagon like peptide-1 receptor agonists (GLP-1 RAs), are not associated […]
Read MoreCME/CPD Provider Number: CPDSO 50212
Commonly used medications for type 2 diabetes and obesity called glucagon like peptide-1 receptor agonists (GLP-1 RAs), are not associated […]
Read MoreAlthough cancers that occur in the gallbladder or bile ducts are rare, their rates are increasing. A recent study provides […]
Read MoreStudying the cellular metabolism of prostate cancer, a team of Duke Health-led researchers identified a key reason hormone therapies eventually […]
Read MoreOak Brook, Ill., USA and Geneva, Switzerland – March 23, 2021 – Leading global executive search and leadership advisory firm […]
Read MoreThe UK Healthcare Pavilion – the first virtual platform showcasing the very best of UK healthcare and Life Sciences – […]
Read MoreLondon/Addis Ababa – 8th February 2021 – Life Science Newswire – Medics.Academy – a revolutionary UK company delivering global access […]
Read MoreIn this paper, we present an Ethereum blockchain-based approach leveraging smart contracts and decentralized off-chain storage for efficient product traceability in the healthcare supply chain.
Read MoreBy Dr Khaled Mohamed Aly Dr Khaled Mohamed Aly is a medical specialist MBBCH; M.S.C Cairo University; ACLS -EP; ATLS-SL […]
Read MoreThe Regeneration Promise is a reader-friendly guide to the world of regenerative medicine and stem cell technology. Most people have […]
Read MoreBack To Top